Daron Evans is currently Managing Director of PoC Capital, LLC, a fund making direct investments into proof-of-concept clinical trials. He also serves as a Director for Zumbro Discovery, a company developing a peptide therapeutic for cardiovascular indications, and CEO and Director of Nephros, a company selling dialysis equipment and medical device water filters. From 2007 to 2013, Mr. Evans served as CFO of Nile Therapeutics (now Capricor). Previously, he worked at multiple Johnson & Johnson companies, co-founded of Applied Neuronal Network Dynamics, and served in various roles at the consulting firms Arthur D. Little and Booz Allen & Hamilton. Mr. Evans received his B.S. in Chemical Engineering from Rice University, his M.S. in Biomedical Engineering from a joint program at the University of Texas at Arlington and Southwestern Medical School and his MBA from the Fuqua School of Business at Duke University.